Crotalaria paulinea, novo hospedeiro natural do vírus do mosaico severo do caupi

Amostras foliares de Crotalaria paulinea apresentando mosaico foram coletadas em São Luiz, MA, e enviadas ao Laboratório de Virologia Vegetal da UFC. As amostras foram testadas por Elisa indireto, contra anti-soros para Cowpea aphid-borne mosaic virus (CABMV) e Cucumber mosaic virus (CMV) e por dupla difusão em àgar contra anti-soro para Cowpea severe mosaic virus (CPSMV). As amostras reagiram somente com o anti-soro para CPSMV, indicando ser C. paulinea mais um hospedeiro natural do vírus. Extratos das folhas de C. paulinea foram inoculados em plantas de caupi (Vigna unguiculata subsp. unguiculata) mantidas em casa de vegetação. Dez dias após a inoculação, as plantas passaram a exibir sintomas de mosaico e a presença do CPSMV foi confirmada por sorologia. Nos estudos de gama de hospedeiros, envolvendo oito espécies botânicas, o isolado de CPSMV obtido de C. paulinea (CPSMV-Cp) infetou sistemicamente somente cultivares de caupi. Estudos de reações de RT-PCR revelaram a presença de uma banda no gel de agarose de 594 pb para o CPSNV-Cp semelhante às de outros isolados de CPSMV. O CPSMV-Cp foi multiplicado em caupi cv. Pitiúba e purificado por clarificação com n-butanol, precipitação viral com PEG e ultracentrifugação. A preparação purificada apresentou um espectro de absorção ultravioleta típico de núcleoproteína com uma razão A260/A280 de 1,7. Coelho da raça Nova Zelândia Branca imunizado com a preparação viral purificada, produziu anti-soro policlonal reativo com CPSMV em dupla difusão em àgar. Este é o primeiro relato sobre a infecção natural de CPSMV em C. paulinea.

Genetic diversity of begomoviruses infecting soybean, bean and associated weeds in Northwestern Argentina

The subtropical Northwestern region of Argentina (provinces of Tucumán, Salta, Jujuy, Santiago del Estero and Catamarca) suffers from a high incidence of the whitefly Bemisia tabaci, and the detection of begomoviruses is also common. The Northwest is the main bean-growing region of the country, and approximately 10% of Argentina's soybean crop is grown in this area. We have used a PCR-based assay to establish the identity and genetic diversity of begomoviruses associated with bean and soybean crops in Northwestern Argentina. Universal begomovirus primers were used to direct the amplification of a fragment encompassing the 5' portion of the capsid protein gene. Amplified fragments were cloned, sequenced and subjected to phylogenetic analysis to determine the sequence identity to known begomoviruses. The data indicated the presence of four distinct begomoviruses, all related to other New World begomoviruses. The prevalent virus, which was present in 94% of bean and soybean samples and also in two weed species, is closely related to Sida mottle virus (SiMoV). A virus with high sequence identity with Bean golden mosaic virus (BGMV) was found in beans. The two remaining viruses displayed less than 89% identity with other known begomoviruses, indicating that they may constitute novel species. One of these putative novel viruses was detected in bean, soybean and tomato samples.

Predominância de begomovírus em tomateiros na região produtora da Ibiapaba, Ceará, e sua detecção natural em plantas daninhas

O tomateiro, Lycopersicon esculentum Mill., hortaliça de grande importância econômica para o Brasil, apresenta muitos problemas fitossanitários, dentre os quais as viroses. Os vírus associados à cultura no país pertencem aos gêneros Begomovirus, mais frequentemente relatado, Potyvirus, Cucumovirus, Tospovirus e Tobamovirus. No Ceará, apesar de relatos da incidência de viroses em tomateiros na Chapada da Ibiapaba, maior região produtora do estado, há escassez de informações sobre a situação atual da ocorrência de begomovírus, nas diversas lavouras daquele agropólo. Assim, foram objetivos deste trabalho: realizar levantamento da presença de begomovírus nas cultivares e híbridos de tomateiro explorados comercialmente na Ibiapaba; verificar a ocorrência de plantas daninhas infectadas e investigar a transmissão artificial de begomovírus isolados de tomateiro e de plantas daninhas para tomateiro. Os testes sorológicos e a PCR realizados detectaram begomovírus em 'Alambra', 'Densus', 'Monalisa', 'Santa Clara', 'Sheila', 'Sofia', 'Raisa-N' e 'TY- Fanny', cultivares e híbridos mais cultivados nas lavouras. Além de begomovírus, Cucumber mosaic virus (CMV) e Potato virus Y (PVY) foram também detectados. As plantas daninhas Amaranthus spinosus, A. viridis, Ageratum conyzoides e Bidens pilosa foram identificadas como hospedeiras naturais de begomovírus. A transmissão de begomovírus de tomateiro para tomateiro ocorreu em inoculações por enxertia e via extrato foliar e de plantas daninhas infectadas para tomateiros sadios somente por enxertia. O levantamento revelou que, à semelhança do que ocorre no restante do país, begomovírus são predominantes nas lavouras de tomate da Ibiapaba e que as plantas invasoras ali encontradas podem ser fontes de infecção viral para a cultura.

PCR multiplex para a detecção de BSV e CMV em bananeiras micropropagadas

Um protocolo de PCR multiplex foi estabelecido para a detecção do Banana streak virus (BSV) e do Cucumber mosaic virus (CMV) em bananeiras micropropagadas. Estes vírus são responsáveis por perdas na produção de bananas em todo o mundo. Alguns trabalhos descrevem a integração do BSV no genoma B da bananeira. Contudo, a existência de bananeiras híbridas livres do BSV tem sido demonstrada. Ademais, determinadas estirpes do CMV não são transmitidas mecanicamente sob condições de laboratório, nem tampouco detectadas por testes sorológicos. Como conseqüência, a indexação de matrizes para cultura de tecido algumas vezes se mostra ineficiente. A metodologia apresentada neste trabalho sobrepõe esta dificuldade, pois se baseia na detecção do ácido nucléico viral presente em amostras foliares de bananeira. Na reação, foram usados os oligonucleotídeos BADNA 1A e BADNA 4, para a detecção do BSV, e "CMV senso" e "CMV antisenso" para a detecção do CMV. Após a eletroforese foi verificada a presença de dois fragmentos de DNA amplificados simultaneamente, um dos quais com 597 pb correspondente ao BSV e o outro, com 488 pb, correspondente ao CMV. Este resultado indica que o PCR multiplex pode ser utilizado como uma ferramenta adicional na indexação do BSV e do CMV em bananeiras propagadas por cultura de tecido.

Avaliação da resistência a tobamovirus em acessos de Capsicum spp.

A resistência em Capsicum spp a tobamovírus é governada pelos genes L¹ a L4. Baseado na capacidade de alguns isolados suplantarem a resistência destes genes, os tobamovírus podem ser classificados nos patótipos P0, P1, P1-2 e P1-2-3. No Brasil, até o momento as três espécies de tobamovírus conhecidas são: Tobacco mosaic virus (TMV), Tomato mosaic virus (ToMV), pertencentes aos patótipos P0 e Pepper mild mottle virus (PMMoV) pertencente ao patótipo P1-2, respectivamente e podem infectar pimentas e pimentões. Oitenta e seis genótipos de pimentão e pimenta foram avaliados quanto à resistência a tobamovírus, sendo 62 de Capsicum annuum, 18 de C. baccatum e seis de C. chinense. Oito acessos de C. annuum, seis de C. baccatum e os acessos ICA #39, Pimenta de cheiro e PI 152225 de C. chinense apresentaram reação de hipersensibilidade ao ToMV, enquanto que o acesso Ancho de C. annuum foi considerado tolerante, permanecendo assintomático, porém permitindo a recuperação do vírus quando inoculado em Nicotiana glutinosa. Para o PMMoV patótipo P1,2 foram avaliados os acessos de pimentão e pimenta considerados resistentes ao ToMV. Somente o PI 152225 de C. chinense desencadeou reação de hipersensibilidade ao PMMoV, sendo fonte potencial de resistência para programas de melhoramento a este vírus no Brasil.

Análise comparativa da região codificadora para a proteína capsidial de isolados de PepYMV e PVY coletados em pimentão

O Potato virus Y (PVY) e Pepper yellow mosaic virus (PepYMV) são as únicas espécies de potyvirus encontradas em pimenta e pimentão no Brasil. A região codificadora para a proteína capsidial de isolados de PepYMV e PVY coletados em pimentão, foi avaliada quanto à variabilidade e presença de motivos específicos aos potyvirus. A identidade da seqüência de aminoácidos na CP entre os isolados de PepYMV foi de 93% a 100%, enquanto que para os de PVY 94% a 98%. Entre os vírus esta variou de 73% a 79%. Foi observada variabilidade nas regiões conservadas da CP. Todos os isolados de PepYMV seqüenciados não apresentaram o motivo DAG na CP, relacionada a transmissão dos vírus por afídeos, enquanto que para as seqüências obtidas de PVY foi observada. Demais domínios como MVWCIENG, ENTERH, QMKAAA e PYMPRYG foram verificadas em ambas espécies.

Detection of genetically modified organisms in soy products sold in Turkish market

PCR-based technique for GMO detection is the most reliable choice because of its high sensitivity and specificity. As a candidate of the European Union, Turkey must comply with the rules for launching into the market, traceability, and labeling of GMOs as established by EU legislation. Therefore, the objective of this study is to assess soybean products in the Turkish market to verify compliance with legislation using qualitative Polymerase Chain Reaction (PCR) assay to detect the presence of GM soybean and to quantify its amount of GM soybean in the samples tested positive using real-time PCR. DNA extracted by the modified CTAB method was properly used for PCR amplification of food materials. The amplification of a 118 bp DNA fragment of the lectin gene from soybean by PCR was successfully achieved in all samples. The GMO screening was based on the detection of 35S promoter and NOS terminator sequences. The GM positive samples were subjected to detection of Roundup ReadyTM soybean (RR) using quantitative real-time PCR. It was found that 100% of the tested food samples contained less than 0.1 per cent of EPSPS gene.

Hepatitis B virus genotypes and mutations in the basal core promoter and pre-core/core in chronically infected patients in southern Brazil: a cross-sectional study of HBV genotypes and mutations in chronic carriers

Introduction In Brazil, little data exist regarding the distribution of genotypes in relation to basal core promoter (BCP) and precore/core mutations among chronic hepatitis B virus (HBV) carriers from different regions of the country. The aim of this study was to identify HBV genotypes and the frequency of mutations at the BCP and precore/core region among the prevalent genotypes in chronic carriers from southern Brazil. Methods Nested-polymerase chain reaction (nested-PCR) products amplified from the S-polymerase gene, BCP and precore/core region from 54 samples were sequenced and analyzed. Results Phylogenetic analysis of the S-polymerase gene sequences showed that 66.7% (36/54) of the patients were infected with genotype D (D1, D2, D3), 25.9% (14/54) with genotype A (A1, A2), 5.6% (3/54) with subgenotype C2, and 2% (1/54) with genotype E. A comparison of virological characteristics showed significant differences between genotypes A, C and D. The comparison between HBeAg status and the G1896A stop codon mutation in patients with genotype D revealed a relationship between HBV G1896A precore mutants and genotype D and hepatitis B e antigen (HBeAg) seroconversion. Genotype D had a higher prevalence of the G1896A mutation and the presence of a thymine at position 1858. Genotype A was associated with a higher prevalence of the G1862T mutation and the presence of a cytosine at position 1858. Conclusions HBV genotype D (D3) is predominant in HBV chronic carriers from southern Brazil. The presence of mutations in the BCP and precore/core region was correlated with the HBV genotype and HBeAg negative status.

Polymorphism in the promoter region of the mannose-binding lectin gene among human T-cell lymphotropic virus infected subjects

The present study investigated the frequency of the mutations at positions -550 and -221 of the mannose-binding lectin (MBL) gene in a sample of 75 human T-cell lymphotropic virus (HTLV) infected patients and 96 HTLV seronegative controls, in order to evaluate the occurrence of a possible association between the polymorphism and HTLV infection. A sequence specific primer-polymerase chain reaction was used for discrimination of the polymorphism. The analysis of allele frequencies at position -550 did not show any significant differences between HTLV infected group and controls, but there was a significant difference at position -221. The comparative analysis of haplotypes frequencies were not significant, but the genotype frequencies between the two groups, revealed a higher prevalence of genotype LYLX (25.3%), associated with medium and low MBL serum levels among HTLV infected subjects. The odds ratio estimation demonstrated that the presence of genotype LYLX was associated with an increased risk of HTLV infection (p = 0.0096; 1.38 < IC95% < 7.7605). There was no association between proviral load and the promoter polymorphism, but when promoter and exon 1 mutations were matched, it was possible to identify a significant higher proviral load among HTLV infected individuals carrying haplotypes correlated to low serum levels of MBL. The present study shows that the polymorphism in the promoter region of the MBL gene may be a genetic marker associated with HTLV infection, and emphasizes the need for further studies to determinate if the present polymorphism have any impact on diseases linked to HTLV infection.

Characterization of polymorphisms in the mannose-binding lectin gene promoter among human immunodeficiency virus 1 infected subjects

The present study investigated the prevalence of mutations in the -550 (H/L) and -221 (X/Y) mannose-binding lectin (MBL) gene promoter regions and their impact on infection by human immunodeficiency virus 1 (HIV-1) in a population of 128 HIV-1 seropositive and 97 seronegative patients. The allele identification was performed through the sequence-specific primer polymerase chain reaction method, using primer sequences specific to each polymorphism. The evolution of the infection was evaluated through CD4+ T-lymphocyte counts and plasma viral load. The allele and haplotype frequencies among HIV-1-infected patients and seronegative healthy control patients did not show significant differences. CD4+ T-lymphocyte counts showed lower levels among seropositive patients carrying haplotypes LY, LX and HX, as compared to those carrying the HY haplotype. Mean plasma viral load was higher among seropositive patients with haplotypes LY, LX and HX than among those carrying the HY haplotype. When promoter and exon 1 mutations were matched, it was possible to identify a significantly higher viral load among HIV-1 infected individuals carrying haplotypes correlated to low serum levels of MBL. The current study shows that haplotypes related to medium and low MBL serum levels might directly influence the evolution of viral progression in patients. Therefore, it is suggested that the identification of haplotypes within the promoter region of the MBL gene among HIV-1 infected persons should be further evaluated as a prognostic tool for AIDS progression.

Hepatitis B virus infection in children, adolescents, and their relatives: genotype distribution and precore and core gene mutations

INTRODUCTION:The objectives of this study were evaluate hepatitis B virus (HBV) serological markers in children and adolescents followed up at the Child Institute of the Hospital das Clínicas, Faculdade de Medicina de São Paulo, Universidade de São Paulo; identify chronic HBV carriers and susceptible individuals in the intrafamilial environment; characterize HBV genotypes; and identify mutations in the patients and household contacts. METHODS: Ninety-five hepatitis B surface antigen-positive children aged <19 years and 118 household contacts were enrolled in this study. Commercial kits were used for the detection of serological markers, and PCR was used for genotyping. RESULTS: Hepatitis B e antigen (HBeAg) was detected in 66.3% (63/95) of cases. Three of the 30 HBeAg-negative and anti-HBeAg-positive patients presented with precore mutations and 11 presented with mutations in the basal core promoter (BCP). Genotype A was identified in 39 (43.8%) patients, genotype D in 45 (50.6%), and genotype C in 5 (5.6%). Of the 118 relatives, 40 were chronic HBV carriers, 52 presented with the anti-HBc marker, 19 were vaccinated, and 7 were susceptible. Among the relatives, genotypes A, D, and C were the most frequent. One parent presented with a precore mutation and 4 presented with BCP mutations. CONCLUSIONS: Genotypes A and D were the most frequent among children, adolescents, and their relatives. The high prevalence of HBV in the families showed the possibility of its intrafamilial transmission.

Molecular analysis of yellow fever virus 17DD vaccine strain

The Oswaldo Cruz Foundation produces most of the yellow fever (YF) vaccine prepared world wide. As part of a broader approach to determine the genetic variability in YF l7D seeds and vaccines and its relevance to viral attenuation the 17DD virus was purifed directly from chick embryo homogenates which is the source of virus used for vaccination of millions of people in Brazil and other countries for half a century. Neutralization and hemagglutination tests showed that the purified virus is similar to the original stock. Furthermore, radioimmune precipitation of 35S-methionine-labeled viral proteins using mouse hyperimmune ascitic fluid revealed identical patterns for the purified 17DD virus and the YF l7D-204 strain except for the 17DD E protein which migrated slower on SDS-PAGE. This difference is likely to be due to N-linked glycosylation. Finally, comparison by northern blot nybridization of virion RNAs of purified 17DD with two other strains of YF virus only fenome-sized molecules for all three viruses. These observations suggest that vaccine phenotype is primarily associated with the accumulation of mutations.

Hepatitis B genotype G and high frequency of lamivudine-resistance mutations among human immunodeficiencyvirus/hepatitis B virus co-infected patients in Brazil

In this study, we evaluated the hepatitis B virus (HBV) genotype distribution and HBV genomic mutations among a group of human immunodeficiency virus-HBV co-infected patients from an AIDS outpatient clinic in São Paulo. HBV serological markers were detected by commercially available enzyme immunoassay kits. HBV DNA was detected using in-house nested polymerase chain reaction and quantified by Cobas Amplicor. HBV genotypes and mutations in the basal core promoter (BCP)/pre-core/core regions and surface/polymerase genes were determined by sequencing. Among the 59 patients included in this study, 55 reported prior use of lamivudine (LAM) or tenofovir. HBV DNA was detected in 16/22 patients, with a genotype distribution of A (n = 12,75%), G (n = 2,13%), D (n = 1,6%) and F (n = 1,6%). The sequence data of the two patients infected with genotype G strongly suggested co-infection with genotype A. In 10 patients with viremia, LAM-resistance mutations in the polymerase gene (rtL180M + rtM204V and rtV173L + rtL180M + rtM204V) were found, accompanied by changes in the envelope gene (sI195M, sW196L and sI195M/sE164D). Mutations in the BCP and pre-core regions were identified in four patients. In conclusion, genotype G, which is rarely seen in Brazil, was observed in the group of patients included in our study. A high prevalence of mutations associated with LAM-resistance and mutations associated with anti-HBs resistance were also found among these patients.

Genetic characterisation of Langerin gene in human immunodeficiency virus-1-infected women from Bahia, Brazil

Studies on human genetic variations are a useful source of knowledge about human immunodeficiency virus (HIV)-1 infection. The Langerin protein, found at the surface of Langerhans cells, has an important protective role in HIV-1 infection. Differences in Langerin function due to host genetic factors could influence susceptibility to HIV-1 infection. To verify the frequency of mutations in the Langerin gene, 118 samples from HIV-1-infected women and 99 samples from HIV-1-uninfected individuals were selected for sequencing of the promoter and carbohydrate recognition domain (CRD)-encoding regions of the Langerin gene. Langerin promoter analysis revealed two single nucleotide polymorphisms (SNPs) and one mutation in both studied groups, which created new binding sites for certain transcription factors, such as NFAT5, HOXB9.01 and STAT6.01, according to MatInspector software analysis. Three SNPs were observed in the CRD-encoding region in HIV-1-infected and uninfected individuals: p.K313I, c.941C>T and c.983C>T. This study shows that mutations in the Langerin gene are present in the analysed populations at different genotypic and allelic frequencies. Further studies should be conducted to verify the role of these mutations in HIV-1 susceptibility.

Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients

Certain host single nucleotide polymorphisms (SNPs) affect the likelihood of a sustained virological response (SVR) to treatment in subjects infected with hepatitis C virus (HCV). SNPs in the promoters of interleukin (IL)-10 (-1082 A/G, rs1800896), myxovirus resistance protein 1 (-123 C/A, rs17000900 and -88 G/T, rs2071430) and tumour necrosis factor (TNF) (-308 G/A, rs1800629 and -238 G/A, rs361525) genes and the outcome of PEGylated α-interferon plus ribavirin therapy were investigated. This analysis was performed in 114 Brazilian, HCV genotype 1-infected patients who had a SVR and in 85 non-responders and 64 relapsers. A significantly increased risk of having a null virological response was observed in patients carrying at least one A allele at positions -308 [odds ratios (OR) = 2.58, 95% confidence intervals (CI) = 1.44-4.63, p = 0.001] or -238 (OR = 7.33, 95% CI = 3.59-14.93, p < 0.001) in the TNF promoter. The risk of relapsing was also elevated (-308: OR = 2.87, 95% CI = 1.51-5.44, p = 0.001; -238: OR = 4.20, 95% CI = 1.93-9.10, p < 0.001). Multiple logistic regression of TNF diplotypes showed that patients with at least two copies of the A allele had an even higher risk of having a null virological response (OR = 16.43, 95% CI = 5.70-47.34, p < 0.001) or relapsing (OR = 6.71, 95% CI = 2.18-20.66, p = 0.001). No statistically significant association was found between the other SNPs under study and anti-HCV therapy response.